differential
Our Principles of Excellence
01
Amazon Certification
Our products are designed to preserve the Amazon for future generations. This certification honors the dedication of our team and traditional communities in advancing sustainable development. We continue to invest in innovative, eco-conscious practices to amplify our positive impact. The Amazon Seal empowers us to expand our reach while inspiring other companies to adopt environmental responsibility, paving the way for a greener, more prosperous future.
02
Sustainable Raw Materials
We ensure processes that respect the Amazon biome’s delicate balance. By merging responsible practices with cutting-edge technology, Hylaea delivers innovation and sustainability to meet global demand for these compounds—without compromising natural resources. Our approach maintains exceptional quality and scalability worldwide.
03
Unmatched Purity
We produce ibogaine and its precursors with over 99% purity, guaranteeing pharmaceutical-grade excellence. Hylaea’s fusion of advanced technology and sustainability ensures reliable, high-performance products for the global market. Through continuous innovation and partnerships, we develop processes that minimize environmental impact while exceeding customer expectations. With expert teams and state-of-the-art facilities, we lead pharmaceutical research, committed to advancing global health.
04
Large-Scale Production & Service
Hylaea operates a robust, scalable production model tailored to serve major players in the global pharmaceutical industry. Our infrastructure ensures consistent supply, high-capacity output, and ongoing innovation to meet evolving sector demands.
05
Patent Registration & Technology Transfer
A patent application is currently underway, underscoring Hylaea’s commitment to innovation, intellectual property protection, and secure technology transfer. This registration will solidify the exclusivity and standardized quality of our production process, positioning Hylaea as the global leader in ibogaine and precursor manufacturing.
A Hylaea é uma empresa brasileira situada no coração da Amazônia, que está na vanguarda da inovação sustentável. Ela se dedica ao desenvolvimento de matéria-prima vegetal em escala, referente a um valioso composto bioativo precursor para a fabricação de substâncias de grande importância para o mercado farmacêutico global.
Esse composto é fundamental para a produção de insumos farmacêuticos de alta qualidade, aplicando práticas sustentáveis no processo e assegurando a escalabilidade da produção. Nossa tecnologia possibilita a viabilidade comercial de insumos farmacêuticos inovadores, oferecendo soluções de licenciamento e transferência de tecnologia para o setor farmoquímico em nível global.
Ao apoiar o avanço científico e industrial, buscamos promover a produção responsável e o acesso a novos recursos terapêuticos, mantendo nosso compromisso com o meio ambiente, enquanto garantimos a evolução de tratamentos médicos para doenças que afetam uma grande parte da população mundial. Com uma abordagem centrada na sustentabilidade, a Hylaea não apenas contribui para a preservação da biodiversidade amazônica, mas também fortalece a economia local por meio da geração de empregos e do incentivo ao desenvolvimento comunitário. A empresa investe continuamente em pesquisa e desenvolvimento, colaborando com universidades e institutos de pesquisa de renome, para expandir o conhecimento científico e encontrar soluções inovadoras que atendam às demandas do mercado.
Além disso, a Hylaea está comprometida com a transparência e a responsabilidade social, estabelecendo parcerias com comunidades indígenas e ribeirinhas para garantir que suas práticas respeitem e valorizem as culturas e tradições locais. Dessa forma, a empresa não apenas protege o meio ambiente, mas também promove a justiça social e o desenvolvimento econômico sustentável, garantindo que seus avanços tecnológicos beneficiem a todos.
Com sua visão de longo prazo e compromisso com a inovação ética, a Hylaea continua a ser um exemplo de como a indústria pode prosperar em harmonia com a natureza, abrindo caminhos para um futuro mais saudável e equilibrado para nosso planeta.
About us
About Hylaea
Hylaea is a Brazilian company at the forefront of sustainable innovation, headquartered in the heart of the Amazon. We specialize in large-scale development of plant-based raw materials, including bioactive precursor compounds critical to the global pharmaceutical market.
Our sustainable practices and scalable production ensure the commercial viability of innovative pharmaceutical ingredients. We offer licensing and technology transfer solutions to the global chemical-pharmaceutical sector, advancing responsible production and access to novel therapies.
By supporting scientific and industrial progress, we champion environmental stewardship while driving advancements in medical treatments for global health challenges. Our sustainability-focused approach not only preserves Amazonian biodiversity but also strengthens local economies through job creation and community development. Hylaea invests in research partnerships with leading universities and institutes to expand scientific knowledge and deliver market-ready solutions. We collaborate with indigenous and riverine communities, ensuring our practices honor cultural traditions and promote social equity.
Through ethical innovation, Hylaea demonstrates how industry can thrive in harmony with nature, forging a healthier, more balanced future for our planet.
Learn a little more about our history
Learn a little more about our history
Ours
Leadership
FAQ
Your questions answered
-
1 - Can Hylaea guarantee large-scale production of ibogaine and its precursors?Yes. Our sustainable, plant-based raw materials ensure year-round sourcing without degrading the Amazon biome.
-
2 - What purity level does Hylaea’s raw material achieve?Our process ensures ibogaine and precursors with up to 99% purity
-
3 - Is technology transfer available to global pharmaceutical corporations?We are finalizing patent documentation with Brazilian authorities, enabling this opportunity in the near future.
-
4 - Does Hylaea employ experts in ibogaine production?Yes. Our team includes specialists in natural pharmaceutical active ingredients, ensuring professionalized, sustainable production.
-
5 - How does Hylaea ensure sustainable resource extraction?We use reforestation of native species in degraded areas, eliminating biome disruption.
-
6 - How does Hylaea align with the UN Sustainable Development Goals (SDGs)?Our work supports SDG 3 (Health/Target 3.5), SDG 8 (Economic Growth/Target 8.2), and SDG 15 (Life on Land/Target 15.1).
Get in
Contact
Ours
Programs and Partners
Ricardo Marques | CEO
Pharmacist with an MSc and PhD in Natural Product Chemistry, and postdoctoral training in Biotechnology and Organic Synthesis. With 22 years of experience in drug discovery from Amazonian species, he founded Hylaea and pioneered the biosynthesis process for ibogaine extraction from Amazonian trees.
Talita Oliveira | COO
Entrepreneur and clinical psychologist specializing in trauma, depression, and anxiety disorders. Integrating evidence-based therapy with innovative mental health solutions.
Jesus Arruda | Cooparechi
Member of the Jaminawa people and leader of the Chico Mendes Reserve Cooperative (sustainable non-timber forest products) - COOPARECHI